安裝中文字典英文字典辭典工具!
安裝中文字典英文字典辭典工具!
|
- 340B Drug Pricing Program | HRSA - Health Resources and . . .
The 340B Program enables covered entities to stretch scarce federal resources as far as possible, reaching more eligible patients and providing more comprehensive services Manufacturers participating in Medicaid agree to provide outpatient drugs to covered entities at significantly reduced prices
- Fact Sheet: The 340B Drug Pricing Program - AHA
Section 340B of the Public Health Service Act requires pharmaceutical manufacturers participating in Medicaid to sell outpatient drugs at discounted prices to health care organizations that care for many uninsured and low-income patients
- Detailed Overview - 340B Health
Read an overview and the requirements of the 340B drug discount program, which aims to provide better health outcomes to the poor and underserved through increased access to prescription medications
- 340B Drug Pricing Program - Wikipedia
The 340B Drug Pricing Program is a US federal government program created in 1992 that requires drug manufacturers to provide outpatient drugs to eligible health care organizations and covered entities at significantly reduced prices
- What Pharmacists Need to Know About the 340B Program
What is the 340B program? The Health Resources and Services Administration, or HRSA, defines the 340B program as a federal program that “enables covered entities to stretch scarce federal resources as far as possible, reaching more eligible patients and providing more comprehensive services ”
- 340B Drug Pricing Program | Medicaid
The 340B Program requires drug manufacturers participating in Medicaid to provide outpatient drugs to covered entities at significantly reduced prices To participate in the 340B Program, covered entities must register and be enrolled with the 340B program and comply with all 340B Program requirements administered by HRSA
- 340B Playbook: A Guide to Understanding the Complex 340B Drug . . .
With the right tools and resources, you can successfully implement a 340B program across ambulatory and specialty care settings Start by getting a big-picture view with our 340B specialty pharmacy white paper, which covers everything from tips for opening a new site of care, to obstacles and risks you might encounter along the way
- 340B Under the Microscope: Key Trends and Takeaways for 2025
The 340B Drug Pricing Program (the Program) has long been a cornerstone for healthcare providers seeking to deliver affordable care to underserved communities However, as the regulatory and compliance landscape evolves, stakeholders—including covered entities, pharmaceutical manufacturers, and pharmacies—must navigate an increasingly complex array of legal requirements and enforcement trends
|
|
|